HEALTH● LOWSep 28 · Sep 28, 2026, 5:45 PM
Retatrutide Diabetes Results , Mounjaro Heart Data , and Wegovy Pill Switching Study Lead EASD 2026 Meeting Opening in Milan
medicaldaily.com · United States · western europe
Key research findings on diabetes drug Retatrutide, heart data for Mounjaro, and a Wegovy pill switching study were presented at the opening of the EASD 2026 Meeting in Milan. This showcases new developments in medical treatments and research.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapUnited States and nearby eventsMore from United StatesLatest stories and threat level
More from United States
POLITICS6h agoHow Trump’s diesel deal with Russia will impact the United States and UkraineDW News [en]MILITARY6h agoStarlink signal cut: Ukraine under pressure from the United StatesLe Figaro InternationalPOLITICS15h agoOfficial and confirmed | The United States can deport foreigners who do not appear at the hearing with Form I-862ClarínPOLITICS1d agoEduardo Bolsonaro and Javier Milei to share an event in the United States, days before the runoff in Brazil and after an arrest warrant against himClarín
More in Health
HEALTH1h agoThe health of Leo XIV: the Pope advances in his recovery, but uncertainty remains about his visit to South AmericaClarínHEALTH1h agoHealthcare workers protest in virtually every state over pay, shortages and staffingMexico News DailyHEALTH2h agoKFF: Individual health insurance enrollment fell 18 percent in JuneThe HillHEALTH2h agoPaxton suing Gerber and Nestlé over alleged arsenic and lead in baby foodThe Hill